H.Res. 672 — Expressing the sense of the House of Representatives that the private-sector distributors of the influenza vaccine should give priority to distributing the available vaccine to those people at a high risk of developing complications from an influenza infection.

H.Res. 672 — Expressing the sense of the House of Representatives that the private-sector distributors of the influenza vaccine should give priority to distributing the available vaccine to those people at a high risk of developing complications from an influenza infection. | PoliFocus

Expressing the sense of the House of Representatives that the private-sector distributors of the influenza vaccine should give priority to distributing the available vaccine to those people at a high risk of developing complications from an influenza infection.

Sponsors

Subjects

Summary

Full Text

Legislative Actions

Ask about this bill